Terrestrial Energy and ANSTO Sign Agreement for Used IMSR Fuel Management
02 févr. 2022 08h29 HE
|
Terrestrial Energy Inc.
SYDNEY, Australia and OAKVILLE, Ontario, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ANSTO, Australia’s knowledge centre for nuclear science and technology, and Terrestrial Energy have agreed to explore ANSTO...
Global Radiopharmaceuticals Market Analysis Report 2021: Market to Reach $8.9 Billion by 2026 - COVID-19 Presents Generational Opportunity
27 janv. 2022 04h43 HE
|
Research and Markets
Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) -- The "Radiopharmaceuticals - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
Raphaël Ortiz Joins Telix as Chief Operating Officer, EMEA
25 janv. 2022 01h29 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and LIÈGE Belgium, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that Raphaël Ortiz has joined the Company...
Global Nuclear Medicine Markets, Analysis, Forecast & Opportunities, 2016-2020 & 2021-2026
31 déc. 2021 09h33 HE
|
Research and Markets
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine Market, By Type, By Diagnostic Nuclear Medicine, By Therapeutic Nuclear Medicine, By Application, By Diagnostic Applications,...
Outlook on the Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Market to 2026 - Featuring Accuray, Bayer Pharma and Nordion Among Others
26 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 26, 2021 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering. This report...
Global Nuclear Medicine/Radiopharmaceuticals Market (2021 to 2026) - Use of Radiopharmaceuticals in Neurological Applications Presents Opportunities
21 sept. 2021 06h23 HE
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha...
Michael Didocha Joins Telix as Chief Financial Officer, Americas
31 août 2021 07h12 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Michael Didocha has joined the...
Mr. Ryoichi Tanaka Joins Telix Japan as Chief Operating Officer
05 août 2021 18h14 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO Japan, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Mr. Ryoichi Tanaka has joined the...
Ms. Helen Hovenga Joins Telix as Chief People Officer
03 août 2021 17h48 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Helen Hovenga has joined the Telix executive...
Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations
11 juil. 2021 18h40 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix...